BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260524T042309EDT-62220periH@132.216.98.100
DTSTAMP:20260524T082309Z
DESCRIPTION:Seminar Announcement\n\n \n\nDR. ALAN SCHNEYER\, PhD\n\nCEO and
  Chief Scientific Officer\n\nFairbanks Pharmaceuticals\n\n \n\nTitle : 'FS
 TL3 neutralizing antibody as a novel diabetes therapy'\n\n \n\nSeminar :\n
 \nMonday\, April 15 \, 2019\n\n12pm - 1pm \n\nMcIntyre Medical Sciences Bu
 ilding\n\nRoom 1345\n\n \n\n \n
DTSTART:20190415T160000Z
DTEND:20190415T170000Z
SUMMARY:DR. ALAN SCHNEYER\, PhD\, CEO and Chief Scientific Officer Fairbank
 s Pharmaceuticals
URL:/pharma/channels/event/dr-alan-schneyer-phd-ceo-an
 d-chief-scientific-officer-fairbanks-pharmaceuticals-295526
END:VEVENT
END:VCALENDAR